The price action defies logic. Well, the selling defies logic I should say.
This close to latest clinical data announcements to be presented from the podium of the AACR... and there are shareholders lining up to sell??? It seems ludicrous.
However, if you look at the charts, recent activity is no different to any other time leading up to trial announcements. The behaviour and, hence, the shareprice movements are the same.
It's almost like VLA does not follow the normal "buy the rumour, sell the news" mentality. Look at the charts in relation to past announcements and the dates of those announcements. Even on the day that trial data is released, the price remains stagnant. It makes its rises days subsequent to the news. Its like the market not only waits for the results, but mulls it over for a day or more!
I want to pick up a few more crumbs between now and then, but there is no rush yet (IF my observations have any logic to them, lol).
I'm with you, Whatsa... "Good luck.. let's get to the podium!!!"
- Forums
- ASX - By Stock
- VLA
- Ann: Viralytics to Present New CAVATAK Clinical Data at AACR
Ann: Viralytics to Present New CAVATAK Clinical Data at AACR, page-51
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online